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Development of in vivo imaging
In Allergology International (AI) Vol. 65 Issue 3, we feature a set of
review articles entitled “Development of in vivo imaging” as well as
an invited review article, original articles, and letters to the editor.
This issue will update you on novel aspects of immune responses
of peripheral immune tissues, such as the skin and central nervous
systems, via in vivo live imaging using two-photon (TP) microscopy.
The immune system constitutes a dynamic network; immune
cells actively move throughout the peripheral organs to scan for
external pathogens. In the past, intravital imaging of peripheral im-
mune responses was performed using confocal or ﬂuorescence mi-
croscopy; however, these techniques have relatively low depth of
light/laser penetration. Therefore, intravital imaging studies of
cutaneous immune responses have been conﬁned to the superﬁcial
areas of peripheral organs.
TP microscopy, using scanning probe microscopes, was ﬁrst
demonstrated by Denk1 and has been in common use for about
10 years. Two-photon excitation is a ﬂuorescence process in which
a ﬂuorophore is excited by the simultaneous absorption of two
photons. Comparedwith conventional single-photon excitationmi-
croscopes, two-photon excitation allows deeper tissue penetration
with less photodamage. TP microscopy therefore allows us to
achieve high spatio-temporal resolution of target tissues.2
TP microscopy has several advantages for observing living tis-
sue. First, some biological components, such as hair shafts and
elastic ﬁbers, are detectable without exogenous probes because of
their own auto-ﬂuorophores.1 In addition, biological tissues contain
many sub-cellular components composed of (a) vitamins or vitamin
derivativesd such as retinol, cholecalciferol, riboﬂavin or pyridox-
ined that emit in the visible light range or (b) aromatic amino acids
such as tyrosine, phenylalanine, and tryptophan that emit in the UV
range.3 Second, collagen ﬁbers, microtubules (tubulin), and muscle
myosin are highly polarizable and are visualized via second har-
monic generation (SHG). Third, some ﬂuorescent-labeled reagents
are available to label tissue components. Boron dipyrromethene
(BODIPY), a lipophilic ﬂuorescent dye, is useful for intravital tissue
imaging. Intravenous injection of BODIPY labels sebaceous gland
and adipocytes.4 In addition, ﬂuorescence-labeled dextran has an
interesting application. It has been reported that the injected
ﬂuorescence-labeled dextran was engulfed by macrophages,5
which allows us to monitor tissue under attack by phagocytic cells.
Transgenic animals that express ﬂuorescent reporter proteins in
speciﬁc tissues or cells are useful for intravital imaging. Many trans-
genic reporter mice have been developed and are used for in vivo
imaging. Ubiquitous reporter strains such as CAG-enhanced green
ﬂuorescent protein (EGFP) are available to label immune cells.6
TP microscopy is at its best observing cell-mediated immune re-
sponses because immune cells represent high motility and rapid
changes in their morphology.7,8 Various kinds of subset-speciﬁc re-
porter strains have been developed that express ﬂuorescent tags
under the control of subset-speciﬁc promoters.9 With these strains,
intravital imaging analyses have elucidated cell behaviors in im-
mune responses.
In this issue, Ishii et al. show us intravital TP imaging of various
tissues and organs, such as live bone, bone marrow, thymus, blood
vessels, and secondary lymphoid organs under the steady or in-
ﬂammatory conditions.10 More speciﬁcally, Honda et al. describe
how skin immune cells cooperate to maintain skin homeostasis
or to exert immune responses against foreign antigens that lead
to allergic skin inﬂammation, such as contact hypersensitivity
response.11 Intriguingly, they found that leukocyte cluster forma-
tion during contact hypersensitivity is essential to activate memory
T cells in the skin. In addition, Kawakami summarizes recent imag-
ing studies of autoreactive Tcell inﬁltration into the central nervous
system.12 Initially, autoreactive T cells interact with endothelial
cells in the airways of the lung or with splenocytes in order to ac-
quire a migratory phenotype to inﬁltrate the central nervous sys-
tem (CNS). Then they interact with endothelial cells before
passing through the bloodebrain barrier. Lastly, CNS-inﬁltrating T
cells are activated by recognizing endogenous autoantigens pro-
duced by local antigen-presenting cells.
Recently, analysis of human biological samples is gaining prom-
inence. In western countries, TP microscopy is being currently
applied to human skin in vivo.13,14 TP microscopy is now used as a
non-invasive diagnostic tool for human tissue diseases and changes,
including tumors, aging, and connective tissue diseases.15 The
attempt to visualize tissue immune responses is, however, just get-
ting started. Because immune cells emit no autoﬂuorescent signals,
ex vivo imaging of biopsy samples in conjunctionwithwhole-mount
immunoﬂuorescence staining techniques will play a pivotal role. At
present, clinical applications using TP microscopy are limited to the
skin,4,16 but TPmicroscopes can be usedwith other humanorgans as
novel systems are developed, such as lensless TP imaging through a
multicore ﬁber with coherence-gated digital phase conjugation.17
Progress in basic science has improved our understanding of the
molecular mechanisms behind various diseases, including allergic
diseases. This has led to a tremendous shift in viewing diseases, a
shift from “phenotypes” to “endotypes”. Focusing on “endotype”
is deﬁned as what uncovers molecular mechanisms underlying
observable characteristics known as “phenotype”. Development of
appropriate “biomarkers” is required for this shift toward the typing
of diseases based on endotypes. “Precision medicine” is deﬁned as
medicine taking individual variability into account and is basedPeer review under responsibility of Japanese Society of Allergology.
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on the recent development of large-scale biological databases,
powerful methods for characterizing patients, and computational
tools.18 Developingmedicines based on endotypeswouldmake pre-
cision medicine a reality. Professors Ioana and Cezmi discuss the
concepts of endotypes, phenotypes, biomarkers, and precision
medicine with relation to allergic diseases,19 suggesting directions
to take in using precision medicine in treating these diseases.
The exhaled nitric oxide fraction (FeNO) is widely used as a
biomarker for airway inﬂammation and as a guide for anti-
inﬂammatory therapy in asthma. However, it has remained unclear
whether a persistently high FeNO in patients with controlled
asthma is associated with the progression of lung dysfunction. In
this issue, Matsunaga et al. report the results of a three-year pro-
spective study of the correlation between the changes of FEV1
and FeNO in 140 patients with controlled asthma.20 They found
that the cut-off value of 40.3 ppb for FeNO identiﬁed the rapid-
decline patients in FEV1 with 43% sensitivity and 86% speciﬁcity.
This suggests using FeNO with well-controlled asthma patients to
identify patients at risk of a progressive loss of lung function.
The2012editionof the JapanesePediatricGuideline for theTreat-
ment and Management of Asthma (JPGL) recommends salmeterol/
ﬂuticasone combination therapy (SFC) as a step 3 to 4 treatment to
control moderate to severe asthma in children aged 5e15 years.21
However, the optimal step-down approach following stabilization
with SFC remains unclear. Akashi et al. report the results of a ran-
domized controlled study of step-down approaches for asthmatic
children controlled by SFC.22 They surveyed 131 subjects who
wereassigned to thehalf-dosinggroup (salmeterol 25mg/ﬂuticasone
50 mg b.i.d., SFC group) or the ﬂuticasone alone group (ﬂuticasone
100 mg b.i.d., FC group) and followed for 12 weeks. They found that
although the FC group showed decreased lung function compared
to the SFC group, there was no signiﬁcant difference in FeNO levels
or C-ACT scores between them. These results suggest that, irrespec-
tive of the effects on lung functions, both halving the dose of SFC and
switching to FP alone are optimal step-down approaches.
We offer our appreciation to all the authors for their contribu-
tions to the present issue of Allergology International.
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